Anissa M. TsonasMichela BottaAry Serpa NetoJanneke HornFrederique PaulusMarcus J. SchultzMelbourne Medical SchoolHogeschool van Amsterdam, University of Applied SciencesUniversity of MelbourneHospital Israelita Albert EinsteinFaculty of Medicine, Nursing and Health SciencesMahidol UniversityNuffield Department of MedicineAmsterdam UMC - University of AmsterdamAmsterdam UMC2022-08-042022-08-042021-01-01Expert Review of Respiratory Medicine. Vol.15, No.8 (2021), 1013-102317476356174763482-s2.0-85104483042https://repository.li.mahidol.ac.th/handle/20.500.14594/78766Introduction: It is uncertain whether ventilation in patients with acute respiratory failure related to coronavirus disease 2019 (COVID-19) differs from that in patients with acute respiratory distress syndrome (ARDS) from another origin. Areas covered: We undertook two literature searches in PubMed to identify observational studies reporting on ventilation management––one in patients with acute respiratory failure related to COVID-19, and one in patients with ARDS from another origin. The searches identified 14 studies in patients with acute respiratory failure related to COVID-19, and 8 studies in patients with ARDS from another origin. Expert opinion: In patients with acute respiratory failure related to COVID-19, ventilation management seems to be similar to that of patients with ARDS from another origin. The future lies in studies focused on personalized treatment of ARDS of all origins, including COVID-19.Mahidol UniversityMedicineReviewSCOPUS10.1080/17476348.2021.1913060